Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-26T21:00:50.192Z Has data issue: false hasContentIssue false

Comparing patient acceptability of MR-guided radiotherapy to conventional CBCT on two Elekta systems: a questionnaire-based survey

Published online by Cambridge University Press:  21 July 2022

Lee Whiteside
Affiliation:
The Christie NHS Foundation Trust, Department of Radiotherapy, Manchester, UK
Claire Nelder
Affiliation:
The Christie NHS Foundation Trust, Department of Radiotherapy, Manchester, UK
Eleanor Pitt
Affiliation:
The Christie NHS Foundation Trust, Department of Radiotherapy, Manchester, UK
Clare Hodgson
Affiliation:
Digital Services, The Christie NHS Foundation Trust, Manchester, UK
Ananya Choudhury
Affiliation:
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
Cynthia L. Eccles*
Affiliation:
The Christie NHS Foundation Trust, Department of Radiotherapy, Manchester, UK Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
*
Author for correspondence: Dr Cynthia Eccles, Radiotherapy Department (39), Research Office, The Christie NHS Foundation Trust, Wilmslow Road, Manchester, M20 4BX, UK. E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Background and Purpose:

The magnetic resonance linear accelerator system (MR Linac) is a novel piece of radiotherapy (RT) equipment allowing the routine application of daily MR-guided treatment adaptation. The hardware design required for such technical capabilities and the increased complexity of the treatment workflow entails a notable departure from cone beam computed tomography (CBCT)-based RT. Patient tolerability of treatment is paramount to RT practice where high compliance is required. Presented is a comparative analysis of how such modality specific characteristics may ultimately impact the patient experience of treatment.

Materials and Methods:

Forty patients undergoing RT for prostate cancer (PCa) on either the MR Linac (n = 20) or a CBCT-based linac (n = 20) were provided with a validated patient reported outcomes measures (PROM’s) questionnaire at fraction 1 and fraction 20. The 18-item questionnaire provided patient responses recorded using a 4-point Likert scale, 0 denoting a response of ‘Not at all’, 1 ‘Slightly’, 2 ‘Moderately’ and 3 signifying ‘Very’. The analysis provided insight into both comparisons between modalities at singular time points (fractions 1 and 20), as well as a temporal analysis within a single modality, denoting changing patient experience.

Results:

Patients generally found the MR Linac treatment couch more comfortable, however, found the increase in treatment duration harder to tolerate. Responses for all items remained stable between first and last fraction across both cohorts, indicating minimal temporal variation within a single modality. None of the responses were statistically significant at the 0·01 level.

Conclusion:

Whether radiotherapy for PCa is delivered on a CBCT linac or the MR Linac, there is little difference in patient experience with minimal experiential variation within a single modality.

Type
Original Article
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Introduction

Within the context of person-centred care, patient experience is an integral component to the evaluation and enhancement of any contemporary health care service, Reference Ocloo and Matthews1 with levels of acceptance shown to provide an effective barometer of adherence to treatment. Reference Hugon, Roustit and Lehmann2,Reference Jacobs, Pensak and Sporn3 Understanding the service user experience through patient reported outcome measures (PROMs) is one such engagement process, questionnaires being a common instrument of assessment. Reference Prinsen, Mokkink and Bouter4 The use of PROMs in healthcare has been shown to improve patient quality of life, satisfaction and wellbeing. Reference Basch, Deal and Kris5,Reference Nipp and Temel6 This is especially vital for therapies in which a high level of patient compliance is crucial for treatment success. However, within radiotherapy where these attributes are paramount, there is a scarcity of information evaluating patient experience of treatment, set-up or comfort. Reference Cheng and Wang7,Reference Olausson, Holst Hansson, Zackrisson, Edvardsson, Östlund and Nyholm8 A distinct lack of consensus exists on what constitutes comfort in the literature, the concept being culturally sensitive, environmentally influenced and encompassing aspects of personal wellbeing. Reference Malinowski and Stamler9 While there is an appreciation that it is crucial to examining the patient experience and treatment-related anxiety, Reference Wensley, Botti, Mckillop and Merry10 there are few well-defined, validated comfort outcome measures available to study. Reference Goldsworthy, Palmer, Latour, McNair and Cramp11

With the introduction and increasing uptake of commercial hybrid magnetic resonance linear accelerator systems (MR Linacs), it seems inevitable that magnetic resonance imaging (MRI) for both planning and treatment will be heavily incorporated into future radiotherapy pathways. Reference Cobben, de Boer and Tijssen1214 While the MR Linac is first and foremost a radiotherapy treatment machine, the patient facing elements of the treatment process and physical system layout are much more closely aligned to that of a conventional MRI scanner. Reference Van Herk, McWilliam, Dubec, Faivre-Finn and Choudhury15 The design choices made to achieve this merging of technologies has the potential to directly impact on the patients experience of the therapeutic environment, their comfort, anxiety levels and the radiographers ability to provide meaningful support. Reference Merchant, O’Connor and Halkett16 Furthermore, the closed bore dimensions, increased noise during sequence acquisitions and the potential for clinically discernible tissue heating are all features not present within mainstream radiotherapy, yet have been shown to negatively impact. Reference Munn and Jordan17,Reference Watt18 The use of fast switching gradients within some MRI acquisitions creates the potential for peripheral nerve stimulation (PNS) within this patient population. Reference Davids, Guerin, Endt, Schad and Wald19 This undesirable biological effect can compromise patient comfort by inducing tingling sensations and ultimately producing involuntary movement as a consequence. Reference Brunnquell, Hoff, Balu, Nguyen, Oztek and Haynor20 As a result, the experience of patients undergoing MR Linac-based treatment has the potential to be vastly dissimilar to those of patients receiving conventional cone beam computed tomography (CBCT) based radiotherapy, yet these metrics remain largely unquantified.

Gaining an understanding of patient issues related to this innovative technique is paramount, since the much-lauded technical potential of the MR Linac could be undermined if a significant reduction in the quality of the patient experience is found. Reference Tetar, Bruynzeel and Bakker21 Furthermore, for a novel therapy in which such gains in accuracy are yet to be translated into meaningful clinical outcomes Reference Van Herk, McWilliam, Dubec, Faivre-Finn and Choudhury15,Reference Winkel, Bol and Werensteijn-Honingh22 it could be unjustified, at this present time, to subject a patient to MR-guided radiotherapy (MRgRT) if the conventional alternative is found to be better tolerated. While the individual sequences used for treatment purposes are significantly shorter than a diagnostic equivalent, the overall treatment duration can be substantially longer than a conventional cone beam-based session. Reference Chin, Eccles and McWilliam23 This is significant when considering that treatment session duration is regarded to be a key contributor to patient discomfort. Reference Boda-Heggemann, Mai and Fleckenstein24,Reference Peguret, Dahele, Cuijpers, Slotman and Verbakel25 Despite the use of immobilisation devices, many cancer patients have comorbidities, making their ability to maintain a stable treatment position over this extended period difficult. Reference Datta, Aznar, Dubec, Parker and O’Connor26 MRI sequences can be highly susceptible to image distortion, such as those introduced through voluntary patient motion, Reference Bangard, Paszek and Berg27,Reference McWilliam, Rowland and van Herk28 the chances of which are likely to increase the longer the patient is on the treatment bed. Reference Bayley, Catton and Haycocks29 In a diagnostic environment, these scans would simply be repeated, however, in radiotherapy they could potentially compromise the geometric integrity of the treatment itself. Additionally, intrafraction internal target and organ at risk (OAR) motion have both been shown to correlate with time, Reference Gill, Dang, Fox, Bressel, Kron and Bergen30 further increasing both treatment complexity and duration.

Throughout the majority of the MR Linac treatment duration, patients spend extended periods with no MR acquisition taking place. Still enclosed within the machine bore, these periods of apparent inactivity may lead patients to be more cognisant of their relative comfort within the clinical environment, such as position, immobilisation and ambiance. The repeated change in stimuli from the more partitioned and protracted approach to sequence acquisition on patient anxiety and acceptability is a factor unexplored and unique to the MR Linac workflow. MRI scan terminations relating to patient anxiety and claustrophobia, necessitating repeat acquisitions, have been reported as high as 9%. Reference Napp, Enders and Roehle31 In a diagnostic setting, such aberrant events are detrimental both financially and to productivity. Reference Dewey, Schink and Dewey32 However, for a therapeutic context in which significant resources have been invested at the pre-treatment and planning stages, this is likely to have a pronounced adverse impact. Anxiety or discomfort over the treatment duration has the potential to seriously undermine the precision afforded by the increased image quality, potentially lowering the therapeutic value. It is therefore imperative to understand the unique factors relating to MRgRT from the perspective of the service users. This work reports the results of the first patient experience comparison for prostate radiotherapy on CBCT and MR Linac-guided systems.

Materials and Methods

At our institution, MRgRT was first implemented in May 2019 on the Elekta Unity system (Elekta AB, Stockholm, Sweden). The unit combines a Philips 1·5 Tesla magnet (Best, The Netherlands) with a 7 MV linear accelerator (Elekta AB, Stockholm, Sweden), allowing for online adaptive planning and real-time tumour tracking throughout treatment delivery.

This audit was undertaken with approval from the local quality assurance and clinical improvement committee (QICA ref: 2610). All patients treated with prostate cancer (PCa) on the MR Linac between May 2019 and October 2020 enrolled in the MOMENTUM study (Clinicaltrials.gov NCT04075305) were included in this audit. During the same timeframe, a matched cohort of patients undergoing prostate radiotherapy on a conventional CBCT-based IGRT system were also included for comparison. Patients received a PROMs questionnaire to compare their treatment experience between the two modalities. Patients from both cohorts were positioned on similar immobilisation consisting of support under the head and knee’s, with arms rested across the chest. Patients undergoing CBCT-based IGRT underwent imaging for the first 3 fractions and then weekly as standard local practice, while the MR Linac cohort underwent multiple image acquisitions on a daily basis. Any premature scan terminations between the cohorts were recorded.

The included questionnaire was developed by McNair and colleagues and adapted from questionnaires created by Ahlander et al. Reference Ahlander, Årestedt, Engvall, Maret and Ericsson33 and Olausson et al. Reference Olausson, Holst Hansson, Zackrisson, Edvardsson, Östlund and Nyholm8 The resulting 18 items generated have subsequently been validated as a tool for accurately reporting patient experience on the MR Linac Reference Barnes, Alexander and Bower34 (Table 1). The questionnaire contains qualitative and quantitative information on coping and discomfort, primarily relating to a range of physical and environmental factors inherent to MR and RT, respectively. Patient responses were recorded on a 4-point Likert scale, 0 denoting a response of ‘Not at all’, 1 ‘Slightly’, 2 ‘Moderately’ and 3 signifying ‘Very’. Questionnaires were distributed on the patient’s first and last fraction, allowing analysis of changes in attitudes and opinions between the two time points. Patients unable to read and write in English were ineligible to take part in the study due to a lack of translational material. No patient demographic data was collected as part of the study.

Table 1. Eighteen-item patient experience questionnaire

Comments:

Questionnaire developed by Helen A McNair, adapted from Olausson et al., Technical Innovations & Patient Support in Radiation Oncology, 2017 and Ahlander et al. Journal of Advanced Nursing.

Parametric methods were used in the analysis of results as the distance between Likert responses was approximately equal across the range of answers. Two sample t-tests were used to compare mean Likert responses for the 2 modalities, and paired t-tests were used to assess change in Likert responses between fraction 1 and fraction 20. A significance level of p < 0·01 was used in order to offset the increased chance of false positives due to multiple statistical tests used. Analysis was performed using Stata version 16.

Results

Forty patients in total participated in this study from both the MR Linac (n = 20) and conventional CBCT linacs (n = 20). All patients received 20 fractions of radiotherapy with a total dose of 6000 cGY. Average treatment length on a conventional linac was 14 minutes (range 8–22 minutes). For the MR Linac cohort, the average treatment length was 39 minutes (range 33–43 minutes).

Comparison of modalities

The differences between the MR Linac and CBCT mean Likert responses were small, ranging from 0·56 to −0·30 across the 18 questions. None of the 2 sample t-tests comparing these mean responses were statistically significant at the 0·01 level. However, there are some trends worth noting.

At each measured time point, the mean Likert response for question 2 ‘I found the treatment bed comfortable’ was higher for the MR Linac patients compared to CBCT treatment, indicating a more favourable opinion of the MR Linac treatment couch. The differences between mean response for question 2 were 0·40 (95% CI: 0·01, 0·79, p = 0·047) for fraction 1 and 0·43 (95% CI: 0·01, 0·86, p = 0·045) for fraction 20. For question 9, ‘I found the time taken for the treatment easy to tolerate’ the mean responses were consistently reported in favour of CBCT-based treatment for both fractions 1 and 20, −0·25 (95% CI: −0·60, 0·10, p = 0·153) and −0·16 (95% CI: −0·33, 0·01, p = 0·067), respectively. Patients in the MR Linac cohort deemed listening to music during treatment (Q. 17) more helpful than the CBCT cohort and this opinion remained static for the two time points measured, with a difference in mean response for fraction 1 of 0·56 (95% CI: −0·12, 1·24, p = 0·103) and 0·41 (95% CI: −0·22, 1·04, p = 0·192) for fraction 20. Patients on the MR Linac also reported tingling sensations at higher rates than their CBCT counterparts (Q. 13) with a difference in mean response of 0·25 (95% CI: 0·01, 0·49, p = 0·038), but also expressed feeling calm during their treatment (Q. 5) session at comparatively higher levels. The differences between mean response for question 5 were 0·20 (95% CI: −0·05, 0·45, p = 0·120) at fraction 1, and 0·15 (95% CI: −0·08, 0·38, p = 0·190) for fraction 20. At fraction 1, the MR Linac cohort expressed the need for fewer communication requirements (Q15) than the patients undergoing CBCT, with a mean difference in scores of −0·20 (95% CI: −0·44, 0·04, p = 0·095); however, by fraction 20, this disparity had all but disappeared (mean: 0·01, 095% CI: −0·39, 0·41, p = 0·958). Figures 1 and 2 compare Likert responses for the 2 cohorts, for fractions 1 and fraction 20, respectively.

Figure 1. Percentage Likert scale of CBCT and MR Linac cohort responses fraction 1.

Figure 2. Percentage Likert scale of CBCT and MR Linac cohort responses fraction 20.

Comparison of first to last treatment

Mean change from fraction 1 to fraction 20 ranged from 0·32 to −0·16 for the MR Linac cohort and from 0·20 to −0·13 for CBCT, across the 18 questions. None of the paired t-tests comparing these mean changes to 0 were statistically significant at the 0·01 level.

On the whole, responses for all items remained stable between first and last fraction, for both modalities. The largest trend identified related to question 7 ‘I found the noise in the room easy to tolerate’, the mean difference between Likert responses for fractions 1 and 20 in the MR Linac cohort being 0·32 (95% CI: −0·02, 0·65, p = 0·083). This indicates that some patients found the noise in the room easier to tolerate at fraction 20 compared to fraction 1. Of note, within this cohort, the requirement for communication during treatment (Q15) increased between the start and end of treatment with the mean difference in the Likert score being 0·21 (95% CI: −0·03, 0·45, p = 0·104).

Question 4 ‘I wanted to come out of the machine during my treatment’ showed no significant mean change in Likert response for either the MRL − 0·11 (95% Cl: −0·44, 0·23, p = 0·54) or CBCT 0·10 (95% Cl: −0·21, 0·41, p = 0·54) cohort between the first and last fractions. Congruent with this, there was no premature scan terminations reported from either cohort throughout the treatment duration. Three MR Linac patients had incomplete data, including one patient who failed to complete the final fraction questionnaire. Five CBCT patients failed to answer individual questions, the vast majority related to the question ‘I found listening to music helpful whilst having my treatment’, likely because no music was playing during their treatment. Patients were omitted from analysis for which their responses were missing.

Overall, results suggest that whether PCa treatment is delivered on a conventional CBCT linac or the MR Linac, there is very little difference in patient experience with minimal temporal variation within a single modality (Figures 3 and 4). No useful qualitative information relating to patient experience was ascertained from the questionnaires and therefore this has not been included within the study results.

Figure 3. Percentage scale of response change for MR Linac patients between fractions 1 and 20.

Figure 4. Percentage scale of response change for CBCT patients between fractions 1 and 20.

Discussion

Since patients disproportionately focus upon the potential adverse impact of treatment and procedural discomforts when making care-focused decisions, Reference Kao, Aranda, Krishnasamy and Hamilton35,Reference Covvey, Kamal and Gorse36 it is valuable to know that there is little variation between treatment as experienced on a CBCT-based conventional linac, when compared to the MR Linac. There is a paucity of research describing the experience of patients treated on hybrid MR linear accelerators. Those few that do exist suggest the technique is well tolerated, Reference Tetar, Bruynzeel and Bakker21,Reference Barnes, Alexander and Bower34,Reference Klüter, Katayama and Spindeldreier37,Reference Andratschk, Day and Schüler38 however, all fail to compare findings across modalities.

Aligned with the high level of acceptance as evidenced by patients willing to remain in the machine bore for a sustained period (Q.4), our study reported no premature scan terminations from the MR Linac cohort. Such claustrophobic events have been shown to correlate with the area of the body being imaged, with lower extremity and pelvic scans showing the least non-completions. Reference Munn, Moola, Lisy, Riitano and Murphy39 Likewise, it is well documented that when the head and neck are immobilised in a thermoplastic shell, the level of anxiety and therefore propensity for such events increases dramatically. Reference Sharp, Lewin, Johansson, Payne, Gerhardsson and Rutqvist40Reference Nixon, Brown and Pigott43 Since our cohort had their pelvic region treated with their upper body relatively free of restraint, generalisations from these results should therefore not be readily applied to other cohorts of patients treated on the MR Linac for disparate disease sites. Furthermore, since our sample of patients had already undergone MRI scans as part of their diagnostic and treatment pathway, it is likely the patients in this study were already familiar and relatively comfortable with the MR environment. Consequently, since the sample was not randomised between the two interventions, more nervous patients may have opted for CBCT radiotherapy and in turn this could have influenced responses to the questionnaire.

More patients from the MR Linac cohort found both the treatment bed and treatment position comfortable on both their first and last fractions when compared with the CBCT cohort. This is likely a result of the slight variation in immobilisation and thin foam mattress used for MR Linac-based treatment. There is the potential that any further gains in comfort may have been negated by the longer time spent maintaining the position for the MR Linac cohort. This corroborates that, when asked whether the time taken for treatment was easy to tolerate, the MR Linac patients answered less favourably than their CBCT counterparts. The merit of a longer, but potentially more comfortable treatment session on the MR Linac is yet to be investigated in relation to treatment accuracy and patient compliance. One centre-specific variable which may have lessened a potential source of discomfort experienced is that the author’s institution employs an empty bladder protocol for this patient group. It has been shown that a substantial source of patient anxiety may arise from the requirement to hold a full bladder for the treatment duration. Reference Sutton, Lane and Davis44 The effect of this untested scenario with regard to longer treatment fractions on the MR Linac may therefore be more explicit in other centres employing this preparation. Of note, the MR Linac cohort reported modestly more experience of tingling sensations throughout the treatment duration; however, this does not appear to have significantly impacted on their relative comfort levels. For this particular cohort, in which short sequences devoid of rapidly switching gradients are employed means this could be expected. For future patient groups with more intensive functional acquisitions, this question will need to be re-addressed. Of note, one limitation of the study is that researchers were more likely to find higher levels of tingling in the MR cohort since it is not a reported complication of CBCT treatment. This is true for a number of questions, for example, the experience of a metallic taste, however, to omit such incidences from the questionnaire tool would exclude information pertinent to patient tolerability.

Although not investigated in this study, the holistic view of patient experience suggests that there may be a relationship between anxiety and the psychological and physical determinants of comfort, with patients who are more anxious at treatment less likely to tolerate maintaining a treatment position. Reference Clover, Oultram, Adams, Cross, Findlay and Ponman45 PCa patients generally report relatively low levels of anxiety at baseline compared to patients from other disease sites, Reference Cox and Davison46 and this may be a factor in the perceived indifference to the change of treatment environment between the two modalities. Similar PCa patient apathy to positional variations and novel immobilisation devices has been reported in the literature. Reference Cox and Davison46,Reference Nutting, Khoo and Walker47 The concept of passivity has been used to describe how patients may cope with unpleasant treatment situations, sacrificing comfort for medical necessity. This heightened level of acceptability has been reported to be more prominent in males, Reference Grassi, Johansen and Annunziata48,Reference Cardoso, Graca, Klut, Trancas and Papoila49 with levels of anxiety often found to be higher in their spouses, Reference Couper, Bloch, Love, Macvean, Duchesne and Kissane50 a possible consequence of hegemonic masculinity. Reference Goldsworthy, Tuke and Latour51 Across the cancer spectrum this may be applied to explain the relatively low uptake of males to seeking cancer information provision, Reference McCaughan, Prue, McSorley, Northouse, Schafenacker and Parahoo52 support services Reference Oliffe, Ogrodniczuk, Bottorff, Hislop and Halpin53,Reference Hedden, Pollock, Stirling, Goldenberg and Higano54 and notably the propensity for our patient sample to disproportionately choose the most extreme favourable response to any given question. The literature reports that regular communication with patients is an effective way to reduce their anxiety regarding radiotherapy immobilisation and treatment, especially at the first fraction. Reference Merchant, O’Connor and Halkett16,Reference Nixon, Cartmill and Turner42 In our study, there was no significant shift in the desire for information provision between modalities or treatment time points. This was perhaps because on the MR Linac, patients were routinely spoken to at multiple time points throughout the treatment duration. On the CBCT units, this was not employed for this patient group since the treatment duration was significantly shorter by comparison.

Due to the relative age and nature of disease, our patient sample was unlikely to be in pain or suffering from significant comorbidities which may have made the treatment less tolerable. Reference Andratschk, Day and Schüler38 This is positive, since it means that the difference in environment and experiential factors between the two modalities will have been judged more objectively, without the influence of patient-specific confounding factors. The provision of music between the two patient cohorts was not tightly controlled in this study and did differ across modalities. This variation, while reflective of the real clinical practice, could potentially have impacted the macrocosmic perception of treatment. However, multiple studies have been unable to find a significant link between music interventions and a subjective experience of radiation treatment. Reference Smith, Casey, Johnson, Gwede and Riggin55Reference O’Callaghan, Sproston and Wilkinson57 The lack of qualitative data points within this research imposes limits on important, useable data that could have been generated. Future studies should aim to make more explicit use of such data sources in order to add depth to feedback.

This study has reported on the experience of a specific cohort of patients undergoing radiotherapy on two different treatment modalities. Future research in this field should expand on this work to include other disease sites, where variations in imaging duration, levels of comorbidity and immobilisation may elicit more significant differences in response.

Acknowledgements

The authors gratefully acknowledge support from Elekta, the NIHR Manchester BRC, Manchester CRN, ARTNET and the work of Helen McNair and The Royal Marsden NHS Foundation Trust in developing the patient experience questionnaire upon which this study is based.

References

Ocloo, J, Matthews, R. From tokenism to empowerment: progressing patient and public involvement in healthcare improvement. BMJ Qual Saf 2016; 25: 626632.CrossRefGoogle ScholarPubMed
Hugon, A, Roustit, M, Lehmann, A et al. Influence of intention to adhere, beliefs and satisfaction about medicines on adherence in solid organ transplant recipients. Transplantation 2014; 98: 222228 CrossRefGoogle ScholarPubMed
Jacobs, J M, Pensak, N A, Sporn, N J et al. Treatment satisfaction and adherence to oral chemotherapy in patients with cancer. J Oncol Pract 2017; 13: e474e485 CrossRefGoogle ScholarPubMed
Prinsen, C A C, Mokkink, L B, Bouter, L M et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res 2018; 27: 11471157.CrossRefGoogle ScholarPubMed
Basch, E, Deal, A M, Kris, M G et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016; 34: 557565.CrossRefGoogle ScholarPubMed
Nipp, R, Temel, J. Editorial: the patient knows best: incorporating patient-reported outcomes into routine clinical care. JNCI 2017; 109: djx044.CrossRefGoogle Scholar
Cheng, F, Wang, W. Factors influencing comfort level in head and neck neoplasm patients receiving radiotherapy. Int J Nur Sci 2014; 1: 394399.Google Scholar
Olausson, K, Holst Hansson, A, Zackrisson, B, Edvardsson, D, Östlund, U, Nyholm, T. Development and psychometric testing of an instrument to measure the patient’s experience of external radiotherapy: the radiotherapy experience questionnaire (RTEQ). Tech Innov Patient Support Radiat Oncol 2017; 3: 712.CrossRefGoogle ScholarPubMed
Malinowski, A, Stamler, L L. Comfort: exploration of the concept in nursing. J Adv Nurs 2002; 39: 599606.CrossRefGoogle ScholarPubMed
Wensley, C, Botti, M, Mckillop, A, Merry, A. A framework of comfort for practice: an integrative review identifying the multiple influences on patients’ experience of comfort in healthcare settings. Int J Qual Health Care 2017; 29: 151162.Google ScholarPubMed
Goldsworthy, S, Palmer, S, Latour, J M, McNair, H, Cramp, M. A systematic review of effectiveness of interventions applicable to radiotherapy that are administered to improve patient comfort, increase patient compliance, and reduce patient distress or anxiety. Radiography 2020; 26: 314324.CrossRefGoogle ScholarPubMed
Cobben, D, de Boer, H, Tijssen, R et al. Emerging role of MRI for radiation treatment planning in lung cancer. Technol Cancer Res Treat 2015; 15: 4760.CrossRefGoogle ScholarPubMed
Bainbridge, H, Salem, A, Tijssen, R et al. Magnetic resonance imaging in precision radiation therapy for lung cancer. Transl Lung Cancer Res 2017; 6: 689707.CrossRefGoogle ScholarPubMed
Society and College of Radiographers MRI guided radiotherapy. The Society and College of Radiographers (online) 2020. https://www.sor.org/getmedia/3be2a7d1-2d57-4d6b-b4ef-60368a3b7eae/mri_guided_radiotherapy-1.pdf_2. Accessed on 22th April 2022.Google Scholar
Van Herk, M, McWilliam, A, Dubec, M, Faivre-Finn, C, Choudhury, A. Magnetic resonance imaging-guided radiation therapy: a short strengths, weaknesses, opportunities, and threats analysis. Int J Radiat Oncol Biol Phys 2018; 101: 10571060.CrossRefGoogle Scholar
Merchant, S, O’Connor, M, Halkett, G. Time, space and technology in radiotherapy departments: how do these factors impact on patients’ experiences of radiotherapy? Eur J Cancer Care 2017; 26: e12354 (1–10).CrossRefGoogle ScholarPubMed
Munn, Z, Jordan, Z. The patient experience of high technology medical imaging: a systematic review of the qualitative evidence. JBI Libr Syst Rev 2011; 9: 631678.CrossRefGoogle ScholarPubMed
Watt, L. Evaluating patient experience in magnetic resonance imaging (MRI). J Med Imaging Radiat Oncol 2014; 58: 335 Google Scholar
Davids, M, Guerin, B, Endt, A, Schad, L R, Wald, L. Prediction of peripheral nerve stimulation thresholds of MRI gradient coils using coupled electromagnetic and neurodynamic simulations. Magn Reson Med 2018; 81: 686701 CrossRefGoogle ScholarPubMed
Brunnquell, C L, Hoff, M N, Balu, N, Nguyen, X V, Oztek, M A, Haynor, D R. Making magnets more attractive. Top Magn Reson Imaging 2020; 29: 167174.Google ScholarPubMed
Tetar, S, Bruynzeel, A, Bakker, R et al. Patient-reported outcome measurements on the tolerance of magnetic resonance imaging-guided radiation therapy. Cureus 2018; 10: e2236.Google ScholarPubMed
Winkel, D, Bol, G H, Werensteijn-Honingh, A M et al. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR Linac SBRT treatments of lymph node oligometastases. Radiother Oncol 2020; 146: 118125.CrossRefGoogle ScholarPubMed
Chin, S, Eccles, C L, McWilliam, A et al. Magnetic resonance-guided radiation therapy: a review. J Med Imaging Radiat Oncol 2019; 64: 115.Google ScholarPubMed
Boda-Heggemann, J, Mai, S, Fleckenstein, J et al. Flattening-filter-free intensity modulated breath-hold image-guided SABR (stereotactic ablative radiotherapy) can be applied in a 15-min treatment slot. Radiother Oncol 2013; 109: 505509 CrossRefGoogle Scholar
Peguret, N, Dahele, M, Cuijpers, J P, Slotman, B J, Verbakel, W. Frameless high dose rate stereotactic lung radiotherapy: intrafraction tumor position and delivery time. Radiother Oncol 2013; 107: 419422 CrossRefGoogle ScholarPubMed
Datta, A, Aznar, M C, Dubec, M, Parker, G J M, O’Connor, J P B. Delivering functional imaging on the MRI-Linac: current challenges and potential solutions. Clin Oncol 2018; 30: 702710.CrossRefGoogle ScholarPubMed
Bangard, C, Paszek, J, Berg, F et al. MR imaging of claustrophobic patients in an open 1.0T scanner: motion artifacts and patient acceptability compared with closed bore magnets. Eur J Radiol 2007; 64: 152157 CrossRefGoogle Scholar
McWilliam, A, Rowland, B, van Herk, M. The challenges of using MRI during radiotherapy. Clin Oncol 2018; 30: 680685.CrossRefGoogle ScholarPubMed
Bayley, A J, Catton, C N, Haycocks, T et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol 2004; 70: 3744.CrossRefGoogle ScholarPubMed
Gill, S, Dang, K, Fox, C, Bressel, M, Kron, T, Bergen, N. Seminal vesicle intrafraction motion analysed with cinematic resonance imaging. Radiat Oncol 2014; 9: 174 CrossRefGoogle ScholarPubMed
Napp, A, Enders, J, Roehle, R et al. Analysis and prediction of claustrophobia during MR imaging with the claustrophobia questionnaire: an observational prospective 18-month single-center study of 6500 patients. Radiology 2017; 283: 148157 CrossRefGoogle ScholarPubMed
Dewey, M, Schink, T, Dewey, C F. Claustrophobia during magnetic resonance imaging: a cohort study in over 55,000 patients. J Magn Reson Imaging 2007; 26: 13221327.CrossRefGoogle ScholarPubMed
Ahlander, B M, Årestedt, K, Engvall, J, Maret, E, Ericsson, E. Development and validation of a questionnaire evaluating patient anxiety during magnetic resonance imaging: the magnetic resonance imaging-anxiety questionnaire (MRI-AQ). J Adv Nurs 2016; 72: 13681380.CrossRefGoogle ScholarPubMed
Barnes, H, Alexander, S, Bower, L et al. Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR Linac. Clin Transl Radiat Oncol 2021; 30: 3137.CrossRefGoogle ScholarPubMed
Kao, C-Y, Aranda, S, Krishnasamy, M, Hamilton, B. Identifying essential information to support patient decision-making regarding participation in cancer clinical trials: a Delphi study. Eur J Cancer Care 2018; 27: e12954.CrossRefGoogle ScholarPubMed
Covvey, J R, Kamal, K M, Gorse, E et al. Barriers and facilitators to shared decision-making in oncology: a systematic review of the literature. Support Care Cancer 2019; 27: 16131637.CrossRefGoogle ScholarPubMed
Klüter, S, Katayama, S, Spindeldreier, C K et al. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany. Strahlenther Onkol 2020; 196: 691698.CrossRefGoogle ScholarPubMed
Andratschk, N, Day, J, Schüler, et al. Initial clinical experience with the MR Linac system – patient perspective 2020. Poster presentation. In: ESTRO 28th Nov – 1st Dec 2020. Session code: 934Google Scholar
Munn, Z, Moola, S, Lisy, K, Riitano, D, Murphy, F. Claustrophobia in magnetic resonance imaging: a systematic review and meta-analysis. Radiography 2015; 21: e59e63.CrossRefGoogle Scholar
Sharp, L, Lewin, F, Johansson, H, Payne, D, Gerhardsson, A, Rutqvist, L E. Randomized trial on two types of thermoplastic masks for patient immobilization during radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 250256.CrossRefGoogle ScholarPubMed
Mullaney, T, Pettersson, H, Nyholm, T, Stolterman, E. Thinking beyond the cure: a case for human-centered design in cancer care. Int J Design 2012; 6: 2739 Google Scholar
Nixon, J L, Cartmill, B, Turner, J et al. Exploring the prevalence and experience of mask anxiety for the person with head and neck cancer undergoing radiotherapy. J Med Radiat Sci 2018; 65: 282290 CrossRefGoogle ScholarPubMed
Nixon, J L, Brown, B, Pigott, A E et al. A prospective examination of mask anxiety during radiotherapy for head and neck cancer and patient perceptions of management strategies. J Med Radiat Sci 2019; 66: 184190 CrossRefGoogle ScholarPubMed
Sutton, E, Lane, J A, Davis, M et al. Men’s experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study. Cancer Causes Control 2021; 32: 261269 CrossRefGoogle ScholarPubMed
Clover, K, Oultram, S, Adams, C, Cross, L, Findlay, N, Ponman, L. Disruption to radiation therapy sessions due to anxiety among patients receiving radiation therapy to the head and neck area can be predicted using patient self-report measures. Psychoncology 2011; 20: 13341341 CrossRefGoogle Scholar
Cox, J, Davison, A. Comfort as a determiner of treatment position in radiotherapy of the male pelvis. Radiography 2005; 11: 109115.CrossRefGoogle Scholar
Nutting, C M, Khoo, V S, Walker, V et al. A randomised study of the use of a customised immobilisation system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol 2000; 54: 19.CrossRefGoogle Scholar
Grassi, L, Johansen, C, Annunziata, M A et al. Screening for distress in cancer patients: a multicenter, nationwide study in Italy. Cancer 2013; 119: 17141721.CrossRefGoogle ScholarPubMed
Cardoso, G, Graca, J, Klut, C, Trancas, B, Papoila, A. Depression and anxiety symptoms following cancer diagnosis: a cross-sectional study. Psychol Health Med 2016; 21: 562570.CrossRefGoogle ScholarPubMed
Couper, J, Bloch, S, Love, A, Macvean, M, Duchesne, G M, Kissane, D. Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature. Psycho-Oncology 2006; 15: 937953.CrossRefGoogle ScholarPubMed
Goldsworthy, S D, Tuke, K, Latour, J M. A focus group consultation round exploring patient experiences of comfort during radiotherapy for head and neck cancer. J Radiother Pract 2016; 15: 143149.CrossRefGoogle Scholar
McCaughan, E, Prue, G, McSorley, O, Northouse, L, Schafenacker, A, Parahoo, K. A randomized controlled trial of a self-management psychosocial intervention for men with prostate cancer and their partners: a study protocol. J Adv Nurs 2013; 69: 25722583 CrossRefGoogle ScholarPubMed
Oliffe, J L, Ogrodniczuk, J, Bottorff, J L, Hislop, T G, Halpin, M. Connecting humor, health, and masculinities at prostate cancer support groups. Psycho-Oncology 2009; 18: 916926.CrossRefGoogle ScholarPubMed
Hedden, L, Pollock, P, Stirling, B, Goldenberg, L, Higano, C. Patterns and predictors of registration and participation at a supportive care program for prostate cancer survivors. Support Care Cancer 2019; 27: 43634373 CrossRefGoogle Scholar
Smith, M, Casey, L, Johnson, D, Gwede, C, Riggin, O. Music as a therapeutic intervention for anxiety in patients receiving radiation therapy. Oncol Nurs Forum 2001; 28: 855862.Google ScholarPubMed
Barry, P, O’Callaghan, C, Wheeler, G, Grocke, D. Music therapy CD creation for initial pediatric radiation therapy: a mixed methods analysis. J Music Ther 2010; 47: 233263.CrossRefGoogle ScholarPubMed
O’Callaghan, C, Sproston, M, Wilkinson, K et al. Effect of self-selected music on adults’ anxiety and subjective experiences during initial radiotherapy treatment: a randomised controlled trial and qualitative research. J Med Imaging Radiat Oncol 2012; 56: 473477.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Eighteen-item patient experience questionnaire

Figure 1

Figure 1. Percentage Likert scale of CBCT and MR Linac cohort responses fraction 1.

Figure 2

Figure 2. Percentage Likert scale of CBCT and MR Linac cohort responses fraction 20.

Figure 3

Figure 3. Percentage scale of response change for MR Linac patients between fractions 1 and 20.

Figure 4

Figure 4. Percentage scale of response change for CBCT patients between fractions 1 and 20.